Financial Summary (All financials)
| In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
| Revenues | 219.1 | 184.3 | 133.9 | 117.7 | 103.1 | 96.2 | 93.7 | 84.7 |
| Revenue growth | 18.8% | 37.6% | 13.8% | 14.1% | 7.2% | 2.7% | 10.6% | 18.7% |
| Cost of goods sold | 85.4 | 75.2 | 46.9 | 52.3 | 42.2 | 41.6 | 40.4 | 33.2 |
| Gross profit | 133.7 | 109.1 | 87.0 | 65.4 | 60.9 | 54.6 | 53.2 | 51.4 |
| Gross margin | 61.0% | 59.2% | 65.0% | 55.5% | 59.1% | 56.8% | 56.8% | 60.7% |
| Selling, general and administrative | -85.4 | | | | | | | |
| Sales and marketing | | 28.3 | 18.5 | 12.9 | 8.3 | 8.8 | 10.0 | 7.5 |
| Research and development | | 15.8 | 10.4 | 6.4 | 3.5 | 3.5 | 4.2 | 4.0 |
| General and administrative | | 60.3 | 45.8 | 38.2 | 31.3 | 26.3 | 22.8 | 23.6 |
| EBITA | 3.3 | 4.7 | 26.9 | 18.6 | 24.9 | 22.9 | 16.3 | 16.3 |
| EBITA margin | 1.5% | 2.6% | 20.1% | 15.8% | 24.2% | 23.8% | 17.4% | 19.3% |
| Amortization of intangibles | | 0.0 | 14.5 | 10.6 | 7.1 | 6.9 | | |
| EBIT | 3.3 | 4.7 | 12.4 | 7.9 | 17.9 | 16.0 | 16.3 | 16.3 |
| EBIT margin | 1.5% | 2.6% | 9.2% | 6.7% | 17.3% | 16.6% | 17.4% | 19.3% |
| Pre-tax income | -0.4 | 3.6 | 2.3 | 3.9 | 8.6 | 0.3 | 14.3 | 15.6 |
| Income taxes | -1.3 | 1.7 | -1.0 | 2.1 | 1.1 | 3.3 | 3.1 | 4.4 |
| Tax rate | 339.1% | 47.6% | | 54.0% | 13.2% | 1084.1% | 21.8% | 28.2% |
| Net income | 0.9 | 1.9 | 3.3 | 1.8 | 7.5 | -3.0 | 11.2 | 11.2 |
| Net margin | 0.4% | 1.0% | 2.4% | 1.5% | 7.3% | -3.1% | 11.9% | 13.2% |
| |
| Diluted EPS | $0.17 | $0.35 | $0.64 | $0.41 | $1.86 | ($0.79) | $2.91 | $2.97 |
| Shares outstanding (diluted) | 5.4 | 5.3 | 5.1 | 4.4 | 4.0 | 3.8 | 3.8 | 3.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|